参考文献/References:
[1] 中华人民共和国卫生部.GB17149.1-1-1997化妆品皮肤不良反应诊断标准及处理原则[S].北京:中国标准出版社,1997.
[2] 中华人民共和国卫生部.GB17149.1-1997化妆品皮肤皮肤病诊断标准及处理原则总则[S].北京:中国标准出版社,1997.
[3] 刘玮,房军,蔡瑞康.化妆品不良反应及其临床监测[J].中国卫生监督杂志,2008,15(3):183-185.
[4] 杨森.化妆品皮肤不良反应诊疗指南[J].中华皮肤科杂志,2018,11(51):783-786.
[5] Alani JI,Davis MD,Yiannias JA.Allergy to cosmetics:a literature review[J].Dermatitis,2013,24(6):283-290.
[6] 谢淑霞,赖维,万苗坚,等.383例化妆品皮肤不良反应临床分析[J].临床皮肤科杂志,2005,34(7):442.
[7] 钟益萍,苏亮,陈勇军,等2016年广州地区913例化妆品不良反应回归性分析[J].皮肤性病诊疗学杂志,2017,24(4):261-263.
[8] Kohl L,Blondeel A,Song M.Allergic contact dermattis from cosmetics.Retrospective analysis of 819 patch-tested patients[J].Dermatology,2002,204(4):334-337.
相似文献/References:
[1]郑结成,徐宁,张杰,等.疑似面部化妆品变应性接触性皮炎58例斑贴试验[J].中国皮肤性病学杂志,2016,(04):369.[doi:10.13735/j.cjdv.1001-7089.201510139]
ZHENG Jie cheng,XU Ning,ZHANG Jie,et al.The Patch Test Results of 58 Cases of Suspected Facial Cosmetic Allergic Contact Dermatitis[J].The Chinese Journal of Dermatovenereology,2016,(02):369.[doi:10.13735/j.cjdv.1001-7089.201510139]
[2]单偶奇,安莉,赵文伟.药疹189例临床分析[J].中国皮肤性病学杂志,2017,(05):511.[doi:10.13735/j.cjdv.1001-7089.201605050]
SHAN Ou-qi,AN Li,ZHAO Wen-wei.Clinical Analysis of 189 Cases of Drug Eruption[J].The Chinese Journal of Dermatovenereology,2017,(02):511.[doi:10.13735/j.cjdv.1001-7089.201605050]
[3]熊林,陆延娜,周晓凤,等.5-氨基酮戊酸光动力疗法治疗基底细胞癌
80例临床分析[J].中国皮肤性病学杂志,2013,(08):796.
XIONG Lin,LU Yan-na,ZHOU Xiao-feng,et al.The Clinical Analysis 5- Aminolevulinic Acid Photodynamic Therapy for 80 Cases Basal Cell Carcinoma[J].The Chinese Journal of Dermatovenereology,2013,(02):796.
[4]刘广仁,韩永智,黄庚史,等.化妆品变应性接触性皮炎93例临床分析[J].中国皮肤性病学杂志,2013,(04):361.
[5]李欣,胡玲玲,刘子重,等.SOD抗自由基喷剂在减轻光动力治疗痤疮不良反应中的应用[J].中国皮肤性病学杂志,2019,(07):783.[doi:10.13735/j.cjdv.1001-7089.201808150]
LI Xin,HU Lingling,LIU Zizhong,et al.Application of SOD Anti-free-radical Spray in Reduction of the Adverse Effects by Photodynamic Therapy in the Treatment of Acne[J].The Chinese Journal of Dermatovenereology,2019,(02):783.[doi:10.13735/j.cjdv.1001-7089.201808150]
[6]马璐,李进岚,赵廷方,等.贵州省81例麻风不良反应特征及相关因素分析[J].中国皮肤性病学杂志,2020,(10):1143.[doi:10.13735/j.cjdv.1001-7089.201910012]
MA Lu,LI Jinlan,ZHAO Tingfang,et al.Analysis of Adverse Reactions and Related Factors in 81 Cases of Leprosy in Guizhou Province[J].The Chinese Journal of Dermatovenereology,2020,(02):1143.[doi:10.13735/j.cjdv.1001-7089.201910012]
[7]宋黎,胡静,陆茂.表皮生长因子受体酪氨酸激酶抑制剂导致皮肤不良反应7例临床分析[J].中国皮肤性病学杂志,2020,(12):1394.[doi:10.13735/j.cjdv.1001-7089.202003113]
SONG Li,HU Jing,LU Mao.Clinical Analysis of Seven Cases of Cutaneous Adverse Reactions Due to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor[J].The Chinese Journal of Dermatovenereology,2020,(02):1394.[doi:10.13735/j.cjdv.1001-7089.202003113]
[8]曹瑞祥,孟静,于建斌,等.司库奇尤单抗对MTX治疗无效的中重度斑块型银屑病13例临床观察[J].中国皮肤性病学杂志,2020,(12):1468.[doi:10.13735/j.cjdv.1001-7089.202005062]
CAO Ruixiang,MENG Jing,YU Jianbin,et al.Clinical Observation on Secukinumab in the Treatment of 13 Cases of Moderate-to-Severe Plaque Psoriasis Responding Inadequately to MTX[J].The Chinese Journal of Dermatovenereology,2020,(02):1468.[doi:10.13735/j.cjdv.1001-7089.202005062]
[9]闫钇岑,刘玮,田燕,等.从皮肤科视角看化妆品监管科学体系的发展与未来[J].中国皮肤性病学杂志,2021,(01):1.[doi:10.13735/j.cjdv.1001-7089.202004169]
YAN Yicen,LIU Wei,TIAN Yan,et al.Development and Prospective of Cosmetic-related Regulatory Science:Views from
Dermatologists[J].The Chinese Journal of Dermatovenereology,2021,(02):1.[doi:10.13735/j.cjdv.1001-7089.202004169]